Effects of Co-infusion of Plasma, Whole Blood and Anticogulants on Their Clotting Activities.

Simple item page
dc.contributor.authorFujita, Hiroshi
dc.contributor.authorIshihama, Yumiko
dc.contributor.authorNishimura, Shigeko
dc.date.accessioned2014-08-04T07:59:44Z
dc.date.available2014-08-04T07:59:44Z
dc.date.issued2014-03
dc.description.abstractAims: Nafamostat mesilate (NM), a protease inhibitor is available for treating acute pancreatitis and disseminated intravascular coagulopathy and it is used as an anticoagulant for hemodialysis in Japan. A plasmapheresis circuit using NM can easily be blockaded. Therefore, we investigated the influence of co-infusion of fresh frozen plasma (FFP), whole blood and NM on clotting activities mainly in the static condition compared with other anticoagulants including heparin sodium and gabexate mesilate. Study Design: In vitro study. Methodology: We investigated the effect of co-incubation of expired FFP and various concentrations of NM (0–0.1mg/mL). We measured the plasma fibrinogen level and activities of factor XIII, anti-thrombin III, protein C (PC) and protein S (PS). In addition, we examined the influence of NM on coagulation tests using whole blood from healthy volunteers. Results: NM reduced PC and PS activities in FFP, although it did not affect plasma fibrinogen levels or the activities of anti-thrombin III or factor XIII. While anti-thrombin III activity and plasma fibrinogen level increased in NM-containing whole blood, PC and PS activities decreased. Gabexate mesilate, sodium heparin and citrate did not reduce the activities of PC or PS. Conclusion: Co-infusion of FFP, whole blood and NM reduces PC and PS activities and we speculate that it may lead to the obstruction of the plasmapheresis circuit when using NM as an anticoagulant.en_US
dc.identifier.citationFujita Hiroshi, Ishihama Yumiko, Nishimura Shigeko. Effects of Co-infusion of Plasma, Whole Blood and Anticogulants on Their Clotting Activities. International Blood Research & Reviews. 2014 Mar-apr:2(2): 87-94.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/153493
dc.language.isoenen_US
dc.source.urihttps://www.sciencedomain.org/abstract.php?iid=391&id=28&aid=3770en_US
dc.subjectCo-infusionen_US
dc.subjectprotease inhibitoren_US
dc.subjectprotein Cen_US
dc.subjectprotein Sen_US
dc.titleEffects of Co-infusion of Plasma, Whole Blood and Anticogulants on Their Clotting Activities.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ibrr2014v2n2p87.pdf
Size:
324.67 KB
Format:
Adobe Portable Document Format
Description:
Original research article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
International Blood Research & Reviews